CN Stock MarketDetailed Quotes

000919 Jinling Pharmaceutical

Watchlist
  • 7.14
  • -0.42-5.56%
Trading Dec 17 13:37 CST
4.45BMarket Cap60.51P/E (TTM)

About Jinling Pharmaceutical Company

The company was formally established on September 8, 1998. On August 27, 1999, the company issued 80 million A-shares on the Shenzhen Stock Exchange and listed on November 18, 1999. The company's main business is pharmaceutical and medical device manufacturing and medical care services. The main products are: Medronin injection/oral solution, ferrous succinate tablets, shiitake mushroom polysaccharide injection, and absorbent gelatin sponge. The company won the honorary title of “Outstanding Rural Revitalization Base for Model Workers” in Henan Province.

Company Profile

Short Name-A金陵药业
Symbol-A000919
Company NameJinling Pharmaceutical Company Limited
Listing DateNov 18, 1999
Issue Price8.40
Shares Offered80.00M share(s)
FoundedSep 8, 1998
Listed ExchangeSZ Stock Exchange
Legal Representativesheng chen
General Managerhai chen
Secretaryyang wang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativeminyierzishu yang
Legal CounselJiangsu Taihe Law Firm
Employees835
Phone025-83118511
Office AddressJinling Pharmaceutical Building, No. 238 Zhongyang Road, Nanjing
Zip Code210009
Registered AddressNo. 58 Xingang Avenue, Nanjing Economic and Technological Development Zone, Nanjing, Jiangsu
Fax025-83112486
Emailjlyyemail@163.com
Websitehttp://www.jlyy1999.com
Business License320192000001028
BusinessLicense projects: pharmaceutical production; pharmaceutical wholesale; drug retail; food production; health food production; food sales; drug clinical trial services; drug import/export; Class II medical device production; Class III medical device production; pharmaceutical Internet information services; beverage production; cosmetics production; packaging and decoration printed matter printing; road cargo transportation (excluding dangerous goods) (projects subject to approval according to law, can only be carried out after approval by relevant departments. Specific business projects are subject to approval results) General projects: organ biochemical pharmaceutical machinery manufacturing; Class 1 Medical device sales; Class I medical device production; Class II medical device sales; Daily mask (non-medical) production; Daily mask (non-medical) sales; Health consulting services (excluding diagnosis and treatment services); Medical research and testing development; Drug testing instrument sales; Technology import and export; Import and export; Import and export agents; Food import and export; Internet sales (except for sales of products requiring permission); Instrument sales; Sales of mechanical parts and components; Technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; trade brokerage; agricultural and sideline products sales; health care Food (pre-packaged) sales (except for items subject to approval according to law, independently carry out business activities based on a business license in accordance with law)

Company Executives

  • Name
  • Position
  • Salary
  • sheng chen
  • Chairman, Directors, Audit Committee Member, Strategy Committee Convener, Nomination Committee Members
  • --
  • qunhong zhang
  • Directors, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • --
  • xiaoqiang cao
  • Directors, Audit Committee Member, Strategy Committee Member, Member of the Remuneration and Assessment Committee
  • --
  • yang wang
  • directors, Board Secretary, VP, Chief Accountant (Finance Officer)
  • --
  • jian wang
  • Directors, Executive Vice President
  • --
  • hai chen
  • Directors, President, Strategy Committee Member
  • --
  • junping kou
  • Independent Directors, Nomination Committee Convener, Audit Committee Member, Member of the Remuneration and Assessment Committee, Strategy Committee Member
  • --
  • yongjian shen
  • Independent Directors, Member of the Remuneration and Assessment Committee, Nomination Committee Members, Audit Committee Convener
  • --
  • yanping gao
  • Independent Directors, Nomination Committee Members, Strategy Committee Member, Remuneration and Assessment Committee Convener, Audit Committee Member
  • --
  • zishu er
  • Securities Affairs Representative
  • --
  • minyi yang
  • Securities Affairs Representative
  • --
  • yusheng zhou
  • Chairman of the Supervisory Board, Auditors
  • --
  • guangyu yan
  • Auditors
  • --
  • guangyou liao
  • Auditors
  • --
  • jian li
  • VP
  • --
  • xin liu
  • Assistant to the President
  • --
  • zhenxin xi
  • Assistant to the President
  • --
  • xinning zhu
  • Assistant to the President
  • --
  • yuanxin fan
  • Assistant to the President
  • --
  • mingyi jia
  • Chief Engineer
  • --
  • quan li
  • Chief Economist
  • --
  • lei niu
  • Employee Supervisors
  • --
  • xiaoling chen
  • Employee Supervisors
  • --
Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-0.09%
The Concept of Old Age
The Concept of Old Age
Intraday-0.21%